{"name":"Synendos Therapeutics AG","slug":"synendos-therapeutics-ag","ticker":"","exchange":"","domain":"synendos.com","description":"Synendos Therapeutics AG is a biotechnology company focused on developing innovative treatments for severe diseases. The company's lead candidate, SYT-510, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPYjF1NkVPbjh3U2Vlcm9DbnpiMXB1dUZEZVBxRHhDVXVoT0VCc2Q3blhtemlvMEVmU2FOMzFLQTI0bHNiQjBDWURHMEZ1NDl1U2pseC1vbzRTZl9lM2VHSzdZYUROd0lldTF2ZWJpTHE4MWp0UUtHZ2paUHc5b1VTM0FpMHE1dUI5c2V1YWJrMXNmY0daNHRNQm9zUHdTUHM?oc=5","date":"2025-10-31","type":"pipeline","source":"startupticker.ch","summary":"More than 20 Swiss biotech companies to exhibit at Bio Europe - startupticker.ch","headline":"More than 20 Swiss biotech companies to exhibit at Bio Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNTkJSU3QwT3A1QWZYMmxQUEU1YmJteHV6dnFIYm90TDJLcWY1aVdJaTkwRkVWMDFjZ2JNVWIzZ2RXQ05QY3puOWtSX205ZW4waHdRdlBUZ184NWlCNm9kY3ByNzBKU3B4dDRMaWsxaVdyWml5dDdZUVhZTi1RQVU3QURYUjdvaThIMDdoeENvMlRUUmt1a2tUckI2MFNDNjJGVUlkdw?oc=5","date":"2025-09-01","type":"pipeline","source":"startupticker.ch","summary":"New Startup Innovation Projects set to advance their technologies - startupticker.ch","headline":"New Startup Innovation Projects set to advance their technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPN1NReUQ1TWh0SV9qbEs1ZEwzcU1kN0FYNERoR3hJaHFtRWw2QjBfVUg3N3VzVVd6UUhnd3RocHlxak1QYUhxam1WbHJQQ1p1OG9ZcS14bERRRVNtMGxCSmFfRm1TcFd0cTRqWEppSmE0Uk1xOWF0Y1hObG1tQUN0MHNTV1hESkk3QzhXWk1sWEZrNzZsdVE?oc=5","date":"2025-08-14","type":"pipeline","source":"startupticker.ch","summary":"Four startups welcome new leaders to accelerate growth - startupticker.ch","headline":"Four startups welcome new leaders to accelerate growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQYTlaQXZPLU0tampoR0ZjWU5CelBLdkJjM0dSckRURkRaMTRlSGhnZXNzUy1jbF9Vb1BkT3ZVNUtwR1ZYa1c2S2VUNXNZcGVDSkZvdlpuYzFBUHhLMXJCZFRFVnlJbXlFODlYNTlRZTR4ajd3S3ZfaFd4T0VjaUlRMTFtd29KT2ctTm9kbzRKMFJNRDNRSHlnU1Q4bHg1N01ILTFncTN2djg0U3ZPaS1STDE4aUFyU2oxakVmalVjTUFlaWs2d2c?oc=5","date":"2024-01-18","type":"trial","source":"Pharmaceutical Technology","summary":"Synendos set to study endocannabinoid inhibitor for neuropsychiatric conditions - Pharmaceutical Technology","headline":"Synendos set to study endocannabinoid inhibitor for neuropsychiatric conditions","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}